PIK3CD and neoplasm: Meghna et al.’s research shows that nanotechnology interacts with PI3K inhibitors (such as PIK-75) through mechanisms such as targeted delivery, improved drug solubility, and enhanced cell uptake, thereby significantly enhancing its efficacy in tumor treatment.